Arterial erectile dysfunction and peripheral arterial disease: Reliability of a new phenotype of endothelial progenitor cells and endothelial microparticles

Journal of Andrology

Volumn 33, Issue 6, 2012, Pages 1268-1275

  Condorelli, Rosita A ^a   Calogero, Aldo E ^a   Vicari, Enzo ^a   Di Pino, Luigi ^a   Giacone, Filippo ^a   Mongioì, Laura ^a   La Vignera, Sandro ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Carotid abnormalities; Late endothelial progenitor cells; Lower limb artery abnormalities

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; LIPOCORTIN 5; PROSTAGLANDIN E1; VASCULAR ENDOTHELIAL CADHERIN;

ADULT; AGED; ARTERIAL INSUFFICIENCY; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD FLOW VELOCITY; CLINICAL PRACTICE; COLOR ULTRASOUND FLOWMETRY; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORPUS CAVERNOSUM; DIAGNOSTIC VALUE; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; ERECTILE DYSFUNCTION; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; LEG ARTERY; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL;

AGED; ALPROSTADIL; CAROTID INTIMA-MEDIA THICKNESS; CELL-DERIVED MICROPARTICLES; ENDOTHELIAL CELLS; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; PENIS; PERIPHERAL ARTERIAL DISEASE; PHENOTYPE; RISK FACTORS; STEM CELLS;

EID: 84874410566     PISSN: 01963635     EISSN: 19394640     Source Type: Journal    
DOI: 10.2164/jandrol.111.015933     Document Type: Article

References (44)

1. Alberti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications: part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med. 1998;15:151-183.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275: 964-967.
3. Benson CB, Aruny JE, Vickers MA Jr. Correlation of duplex sonography with arteriography in patients with erectile dysfunction. Am J Roentgenol. 1993;160:71-73.
4. Bernard S, Loffroy R, Sérusclat A, Boussel L, Bonnefoy E, Thévenon C, Rabilloud M, Revel D, Moulin P, Douek P. Increased levels of endothelial microparticles CD144 (VE cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computer tomography (MDCT). Atherosclerosis. 2009;203:429-435.
5. Bluth EI, Wetzner SM, Stavros AT. Carotid duplex sonography: a multicenter recommendation for standardized imaging and Doppler criteria. Radiographics. 1988;8:487-506.
6. Breviario F, Caveda L, Corada M, Martin-Padura I, Navarro P, Golay J, Introna M, Gulino D, Lampugnani MG, Dejana E. Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium specific cadherin. Arterioscler Thromb Vasc Biol. 1995;15:1229-1239.
7. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloch IH. Diagnostic evaluation of the erectile function domain of the international index of erectile dysfunction. Urology. 1999;54:346-351.
8. Caretta N, Palego P, Schipilliti M, Ferlin A, Di Mambro A, Foresta C. Cavernous artery intima-media thickness: a new parameter in the diagnosis of vascular erectile dysfunction. J Sex Med. 2009;6: 1117-1126.
9. Chironi GN, Simon A, Boulanger CM, Dignat-George F, Hugel B, Megnien JL, Lefort M, Freyssinet JM, Tedgui A. Circulating microparticles may influence early carotid artery remodeling. J Hypertens. 2010;28:789-796.
10. Corada M, Liao F, Lindgren M, Lampugnani MG, Breviario F, Frank R, Muller WA, Hicklin DJ, Bohlen P, Dejana E. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. Blood. 2001;97: 1679-84.
11. Davizon P, López J. Microparticles and thrombotic disease. Curr Opin Hematol. 2009;16:334-341.
12. Delva P, De Marchi S, Prior M, Degan M, Lechi A, Trettene M, Arosio E. Endothelial progenitor cells in patients with severe peripheral arterial disease. Endothelium. 2008;15:246-253.
13. Esposito K, Ciotola M, Giugliano F, Schisano B, Improta L, Improta MR, Beneduce F, Rispoli M, De Sio M, Giugliano D. Endothelial microparticles correlate with erectile dysfunction in diabetic men. Int J Impot Res. 2007;19:161-166.
14. European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D; ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011;32:1769-1818.
15. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-1053.
16. Fadini GP, Coracina A, Baesso I, Agostini C, Tiengo A, Avogaro A, de Kreutzenberg SV. Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke. 2006;37:2277-2282.
17. Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, Delia D, Sutherland DR, Baker MA, Greaves MF. Expression of the CD34 gene in vascular endothelial cells. Blood. 1990;75:2417-2426.
18. Foresta C, De Toni L, Biagioli A, Ganz F, Magagna S, Caretta N. Increased levels of osteocalcin-positive endothelial progenitor cells in patients affected by erectile dysfunction and cavernous atherosclerosis. J Sex Med. 2010;7:751-757.
19. Gareth WL, Phillips MRCP. Review of arterial vascular ultrasound. World J Surg. 2000;24:232-240.
20. Güven H, Shepherd RM, Bach RG, Capoccia BJ, Link DC. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol. 2006;48:1579-1587.
21. Jackson G. Erectile dysfunction and cardiovascular disease. Int J Clin Pract. 1999;53:363-368.
22. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol. 2004;43:179-184.
23. Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol. 2005;45:1622-1630.
24. La Vignera S. New immunophenotype of circulating endothelial progenitor cells and endothelial microparticles in patients with erectile dysfunction and metabolic syndrome: effects of tadalafil administration. Int Angiol. 2011;30:415-423.
25. La Vignera S, Condorelli R, D'Agata R, Vicari E, Calogero AE. Dysfunction of the endothelial-platelet pathway in patients with erectile dysfunction before and after daily treatment with tadalafil. Andrologia. 2012a;44:152-156.
26. La Vignera S, Condorelli R, Vicari E, D'Agata R, Calogero A. Aerobic physical activity improves endothelial function in the middle-aged patients with erectile dysfunction. Aging Male. 2011a; 14:265-272.
27. La Vignera S, Condorelli R, Vicari E, D'Agata R, Calogero A. Circulating endothelial progenitor cells and endothelial microparticles in patients with arterial erectile dysfunction and metabolic syndrome. J Androl. 2012b;33:202-209.
28. La Vignera S, Condorelli R, Vicari E, D'Agata R, Calogero A. Endothelial antioxidant compound prolonged the endothelial antiapoptotic effects registered after tadalafil treatment in patients with arterial erectile dysfunction. J Androl. 2012c;33:170-175.
29. La Vignera S, Condorelli R, Vicari E, D'Agata R, Calogero A. Original immunophenotype of blood endothelial progenitor cells and microparticles in patients with isolated arterial erectile dysfunction and late onset hypogonadism: effects of androgen replacement therapy. Aging Male. 2011b;14:183-189.
30. La Vignera S, Condorelli RA, Vicari E, D'Agata R, Calogero AE. Endothelial apoptosis decrease following tadalafil administration in patients with arterial ED does not last after its discontinuation. Int J Impot Res. 2011c;23:200-205.
31. La Vignera S, Condorelli RA, Vicari E, D'Agata R, Calogero AE. New immunophenotype of blood endothelial progenitor cells and endothelial microparticles in patients with arterial erectile dysfunction and late-onset hypogonadism. J Androl. 2011d;32:509-517.
32. La Vignera S, Vicari E, Condorelli RA, Di Pino L, Calogero AE. Arterial erectile dysfunction: reliability of penile Doppler evaluation Integrated with serum concentrations of late endothelial progenitor cells and endothelial microparticles. J Androl. 2012d; 33:412-419.
33. Moneta GL, Yeager RA, Antonovic R. Accuracy of lower extremity arterial duplex mapping. J Vasc Surg. 1992;15:275-283.
34. SandriM, Adams V, Gielen S, Linke A, Lenk K, Kränkel N, LenzD, Erbs S, ScheinertD, Mohr FW, Schuler G, Hambrecht R. Effects of exercise and ischemia on mobilization and functional activation of bloodderived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation. 2005;111:3391-3399.
35. Shantsila E, Kamphuisen PW, Lip GY. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost. 2010;8:2358-2368.
36. Shet AS. Characterizing blood microparticles: technical aspects and challenges. Vasc Health Risk Manag. 2008;4:769-774.
37. Sinning JM, Losch J, Walenta K, Böhm M, Nickenig G, Werner N. Circulating CD31+/annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J. 2011;32:2034-2041.
38. Speel TG, van Langen H, Wijkstra H, Meuleman EJ. Penile duplex pharmaco-ultrasonography revisited: revalidation of the parameters of the cavernous arterial response. J Urol. 2003;169:216-220.
39. Thomas ML. The leukocyte common antigen family. Annu Rev Immunol. 1989;7:339-369.
40. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-E7.
41. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis-flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods. 1995;184:39-51.
42. Vicari E, Di Pino L, La Vignera S, Fratantonio E, Signorelli S, Battiato C, Calogero AE. Peak systolic velocity in patients with arterial erectile dysfunction and peripheral arterial disease. Int J Impot Res. 2006;18:175-179.
43. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet. 1985; 26:181-184.
44. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999-1007.